Skip to main content
. Author manuscript; available in PMC: 2018 Aug 7.
Published in final edited form as: Org Lett. 2004 Aug 5;6(16):2661–2664. doi: 10.1021/ol049159x

Table 3.

Allylic Aminations to Vigabatrin Derivative 20

graphic file with name nihms983015u3.jpg
a no. ligand yieldb eec confd
1 (R,R)-Me-DUPHOS (10a) 93% 66% R
2 (S,S)-iPr-DUPHOS (10b) 90% 47% R
3 (S,S)-Et-FerroTANE (11) 28% 8% S
4 JOSIPHOS-type (12a) 55% 31% R
5 JOSIPHOS-type (12b) 28% 74% R
6 JOSIPHOS-type (12c) 23% 22% S
7 JOSIPHOS-type (12d) 73% 5% S
8 JOSIPHOS-type (12e) nr
9 JOSIPHOS-type (12f) 46% 36% R
10 WALPHOS-type (13a) 8% 32% S
11 WALPHOS-type (13b) 60% 53% S
12 (R)-BINAP (15a) 70% 43% R
13 (R)-Tol-BINAP (15b) 84% 44% R
14e (S)-MeO-BIPHEP (16a) 97% 53% S
15 (R)-Me2-OMe-BIPHEP (16b) 65% 54% R
16 (R)-tBu2-OMe-BIPHEP (16d) 60% 23% R
a

Reaction conditions: 67 mM 19, 10 mol% Ni(cod)2, 20 mol% ligand, LiHMDS (1 eq.), THF, rt, overnight.

b

Isolated yields of pure products. nr = no reaction observed.

c

ee’s determined by chiral HPLC (Chiralcel OD: hexane/i-PrOH 73/27).

d

Configuration assigned by correlation with the known γ-lactam, following PMP deprotection (CAN, MeCN, H2O): [α]23D (66% ee-chiral HPLC-see SI) –23.7 (EtOH, c 2.0); Lit.: [α]23D {(S)-isomer} +50.4 (EtOH, c 2.2) - ref. 6e.

e

No exogenous base used (i.e. no LiHMDS).